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Abstract
Background: Stromal cell-derived factor-1 (SDF1) and its major signaling receptor, CXCR4, were initially described
in the immune system; however, they are also expressed in the nervous system, including the spinal cord. After
spinal cord injury, the blood brain barrier is compromised, opening the way for chemokine signaling between
these two systems. These experiments clarified prior contradictory findings on normal expression of SDF1 and
CXCR4 as well as examined the resulting spinal cord responses resulting from this signaling.
Methods: These experiments examined the expression and function of SDF1 and CXCR4 in the normal and injured
adult mouse spinal cord primarily using CXCR4-EGFP and SDF1-EGFP transgenic reporter mice.
Results: In the uninjured spinal cord, SDF1 was expressed in the dorsal corticospinal tract (dCST) as well as the
meninges, whereas CXCR4 was found only in ependymal cells surrounding the central canal. After spinal cord
injury (SCI), the pattern of SDF1 expression did not change rostral to the lesion but it disappeared from the
degenerating dCST caudally. By contrast, CXCR4 expression changed dramatically after SCI. In addition to the
CXCR4+ cells in the ependymal layer, numerous CXCR4+ cells appeared in the peripheral white matter and in the
dorsal white matter localized between the dorsal corticospinal tract and the gray matter rostral to the lesion site.
The non-ependymal CXCR4+ cells were found to be NG2+ and CD11b+ macrophages that presumably infiltrated
through the broken blood-brain barrier. One population of macrophages appeared to be migrating towards the
dCST that contains SDF1 rostral to the injury but not towards the caudal dCST in which SDF1 is no longer present.
A second population of the CXCR4+ macrophages was present near the SDF1-expressing meningeal cells.
Conclusions: These observations suggest that attraction of CXCR4+ macrophages is part of a programmed
response to injury and that modulation of the SDF1 signaling system may be important for regulating the
inflammatory response after SCI.
Background
Chemokines, originally described for their role in pro-
moting the migration of leukocytes during inflammatory
responses, have many well-established pro-inflammatory
and pro-migratory roles in the immune system. More
recently they have been found to have numerous impor-
tant functions in the nervous system as well [1-3]. In
the developing brain, neurons and glia express various
chemokine receptors and are therefore potential targets
for chemokine signaling [2,3]. For example, neonatal oli-
godendrocyte maturation and myelination, axonal
growth, neuronal proliferation and neuronal survival are
just a few of the normal processes regulated by chemo-
kines and particularly by one chemokine pair, stromal
cell-derived factor-1 (SDF-1; also known as CXCL12)
with its receptor CXC chemokine receptor 4 (CXCR4)
[4-11].
After spinal cord injury (SCI) the blood-brain barrier
is compromised leading to a large infiltration of macro-
phages. Beneficial as well as deleterious effects have
been ascribed to immune cells that infiltrate the nervous
system after neural injury, including SCI [12-18]. Since
cells of both the nervous and immune systems express
SDF1 and CXCR4, chemokine signaling between these
cells could regulate spinal cord responses to injury.
However, due to contradictory reports of SDF1/CXCR4
signaling in the spinal cord and following SCI, their role
remains unclear [19-22]. In the adult spinal cord
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GABAergic neurons [20] and corticospinal motor neu-
rons [22] reportedly express CXCR4. Further, levels of
SDF1 mRNA increase 7 days after SCI suggesting a pos-
sible role in injury responses [21]. We therefore sought
to define the expression and possible function of SDF1
and its receptor, CXCR4 in the normal spinal cord and
after SCI. We observed that in the normal spinal cord,
SDF1 is expressed by the dorsal corticospinal tract
(dCST) and by the meninges whereas ependymal cells
express CXCR4. After SCI, infiltrating macrophages and
perhaps ependymal cells, both of which express CXCR4,
appear to migrate towards both the dCST and menin-
geal sources of SDF1. Another population of CXCR4+
cells remains in the ependymal layer after SCI. These
observations suggest that this signaling system may help
to regulate inflammatory responses after SCI, particu-
larly in the dorsal spinal cord.
Methods
Animals
The transgenic mice used in this study (all kindly pro-
vided by Richard Miller, Northwestern University) were
CXCR4-EGFP (CXCR4BAC::EGFP) and SDF-1-EGFP
(SDF-1BAC::EGFP) from The Rockefeller University,
New York, NY and The Gene Expression Nervous Sys-
tem Atlas (GENSAT) project, National Institute of Neu-
rological Disorders and Stroke contract N01Nso2331 to
The Rockefeller University, New York, NY http://www.
gensat.org. All animal-related procedures were approved
by the Northwestern University animal care and use
committee.
Spinal cord injury
Adult mice are anesthetized using inhalation anesthetic
(2.5% isofluorane in 100% oxygen which was adminis-
tered using VetEquip Rodent anesthesia machine). After
laminectomy at the T10 vertebral segment, the spinal
cord was compressed dorsoventrally by the extradural
application of a 24 g modified aneurysm clip for 1 min
(FEJOTA mouse clip). After SCI, the skin was sutured
using AUTOCLIP (9 mm; BD Biosciences, San Jose,
CA). Bladders were manually emptied twice daily
throughout the duration of the study. Post surgery and
in the event of discomfort, Meloxicam (0.3 mg/kg, s.c.,
once daily) was administered. Gentamycin was adminis-
tered once daily in the event of hematuria (20 mg/kg)
subcutaneously for 5 d.
Dextran dye injection
Adult mice were anesthetized with Avertin and were
injected with mini-ruby-conjugated BDA (Invitrogen)
using a 10 μl Hamilton microsyringe fitted with a
pulled-glass micropipette. The corticospinal tract was
labeled with three injections (0.5 μl each) made at 1.0
mm lateral to the midline at 0.5 mm anterior, 0.5 mm
posterior, and 1.0 mm posterior to bregma, and at a
depth of 0.5 mm from the cortical surface. Animals
were sacrificed 14 d after BDA injection and perfused.
Animal perfusions and tissue acquisition
Animals were sacrificed using an overdose of carbon
dioxide and transcardially perfused with PBS followed
by 4% paraformaldehyde in PBS. The spinal cords were
dissected and either fixed overnight in 30% sucrose in
4% PFA or fixed for 2 hours in 4% PFA and dehydrated
overnight in 30% sucrose. The spinal cords were then
frozen in Tissue-Tek embedding compound and sec-
tioned on a Leica (Deerfield, IL) CM3050 S cryostat at
20 μm.
Immunohistochemistry
Sections were rinsed with PBS thrice and then incubated
with blocking solution (10% normal goat serum, 0.25%
TritonX-100, 1% BSA in PBS) at room temperature for
1 hour. The sections were again rinsed thrice with PBS
and incubated with primary antibody [(GFAP; 1:250;
mouse monoclonal IgG1; Sigma), (CD11b; 1:200; rat
monoclonal IgG2b; Serotec), (Nestin; 1:200; mouse
monoclonal IgG1; Abcam), (NG2; 1:200; rabbit; Chemi-
con), (RC2; 1:8; mouse monoclonal IgM, DSHB) in
blocking solution without NGS at 4 deg C overnight.
The SDF1-EGFP and CXCR4-EGFP expression in these
reporter mice was very strong and required no antibody
amplification. After this, sections were rinsed thrice with
PBS and incubated with Alexa Fluorconjugated second-
ary antibodies (1:500; Invitrogen, Carlsbad, CA) for 1 h
at room temperature. Sections were finally rinsed thrice
with PBS and then incubated with Hoechst nuclear stain
in PBS for 10 minutes at room temperature. After a
final rinse with PBS, they were mounted using Prolong
Gold anti-fade reagent (Invitrogen) and imaged using a
Zeiss (Thornwood, NY) UVLSM-Meta confocal micro-
scope or Axiovert fluorescent microscope with the Axio-
camHR camera.
Results
SDF1 and CXCR4 expression in the normal, uninjured
spinal cord
We first examined expression patterns of SDF1 and
CXCR4 in the intact adult spinal cord using well
described CXCR4-EGFP and SDF1-EGFP transgenic
reporter mice [23,24]. In this as in the following experi-
ments, the EGFP expression in these reporter mice was
very strong and required no antibody amplification.
SDF1 was strongly expressed by meningeal cells in the
adult spinal cord (Figure 1a, 2a, c) analogous to findings
in the brain [25]. Interestingly, however, SDF1 was also
highly expressed in the dorsal funiculus in what appears
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to be the dorsal corticospinal tract (dCST) (Figure 1a-e).
To confirm the localization in the dCST, BDA-labeled
dye was injected into motor cortex to label the tract.
SDF1-EGFP (Figure 1c) and BDA-labeled dye (Figure
1d) were colocalized to the same fibers (Figure 1e-g)
confirming expression by dCST neurons. By contrast,
CXCR4-EGFP+ cells were only found in the ependymal
layer (Figure 1h). Therefore, in the adult uninjured
spinal cord, SDF1 and CXCR4 are expressed in separate,
nonadjacent regions.
Figure 1 SDF1 and CXCR4 expression in the normal spinal cord. SDF1 is expressed throughout the dCST (a-g) a-b, Cross sections of SDF1-
GFP mouse spinal cords show SDF1 in the meninges as well as in the dCST. Rhodamine labeled dextran injection into the sensorimotor cortex
shows co-label of SDF1 and dextran dye confirming presence of SDF1-GFP in the dCST (c-g)(red:biotin, green:SDF1-EGFP, blue:Hoechst). e-g,
Magnified images of the boxed area of c and d further demonstrating co-label of SDF1 and dCST label. h. The cognate receptor of SDF1, CXCR4,
is found only in the ependymal layer (green:CXCR4-EGFP, blue:Hoechst). Scale bars a: 200 μm, b-d: 50 μm, h:20 μm.
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SDF1 expression following SCI
To investigate SDF1expression following SCI, we used a
severe clip compression model of SCI that produces a
consistent injury in mice where an initial impact is fol-
lowed by persistent compression analogous to most
cases of human SCI [26,27]. At 5 weeks post SCI, SDF1
was still found in the meninges (Figure 2a) and in the
dCST rostral to the lesion (Figure 2a, c). However SDF1
expression was no longer detectable in the area of the
dCST caudal to the lesion site (Figure 2b, d). Longitudi-
nal sections containing the dCST demonstrated the ter-
mination and dissipation of the tract at the lesion site
(Figure 2gh). At the site of injury, SDF1 was also
expressed by infiltrating cells that were largely restricted
to the lesion epicenter by the glial scar (Figure 2ef).
CXCR4 expression in the injured spinal cord
The pattern of CXCR4 expression changed dramatically
in the spinal cord 5 weeks following SCI. CXCR4-GFP+
cells continued to be present in the ependymal layer,
although there appeared to be fewer than in the unin-
jured spinal cord (Figure 3a-d, Figure 4a-b, d-e, g-h, j-
k). However there were also numerous CXCR4+ cells
that appeared to be migrating towards the periphery of
the spinal cord, possibly towards the SDF1 expressed by
the meninges. CXCR4-GFP+ cells were also present in
the dorsal funiculus of the spinal cord, located between
the dCST and the gray matter, but only rostral to the
injury where SDF1 continued to be present. Although
occasional CXCR4+ cells resided within the lesion epi-
center and scar, most of them resided outside of it (Fig-
ure 3f-h). CXCR4 and GFAP expression did not overlap
at all within the scar indicating that astrocytes do not
express the receptor (Figure 3g).
Figure 2 5 weeks post SCI, SDF1 is found in the dCST rostral
to the injury and inside the lesion epicenter. Thoracic cross
sections demonstrate SDF1-GFP in the dCST rostral (a, c), but not
caudal (b, d) to the injury, however, the SDF1 is present in the
meninges throughout (a-d)(green:SDF1-EGFP, blue:Hoechst). A
longitudinal section that does not contain the dCST shows some
migrating cells expressing SDF1, but most are trapped within the
lesion epicenter by the GFAP+ scar (e, f). Longitudinal sections
containing the dCST show the end of the tract at a cavitation noted
by the high density of nuclei and the GFAP+ scar around its rim (g,
h)(red:GFAP, green:SDF1-EGFP, blue:Hoechst) Scale bars: a-b, e: 200
μm, c-d, h: 50 μm, f: 25, g: 100 μm.
Figure 3 5 weeks post SCI, CXCR4 is found in 3 different areas
of the spinal cord. Thoracic cross sections demonstrate CXCR4-GFP
in the ependymal layer (a-d), peripherally toward the meninges (a-e)
and in the dorsal funiculus rostral to the injury (a, c) but not caudal
to it (b, d)(green:CXCR4-EGFP, blue:Hoechst). Longitudinal sections
show CXCR4-GFP+ cells in the lesion epicenter as noted in f and in
the cavitation in h, but also outside the lesion (f, h). Some CXCR4-
GFP cells were found within the GFAP+ scar, but were distinct from
the GFAP+ cells (g)(red:GFAP, green:CXCR4-EGFP, blue:Hoechst).
Scale bars: a-b, f: 200 μm, c-d, e, h: 50 μm, g:25 μm.
Figure 4 CXCR4-GFP cells appear in the periphery and in the
dorsal funiculus in 2 weeks. At 24 hours post injury, CXCR4-GFP
cells appear throughout the gray and white matter, but this
expression is gone by 4 days post injury(a-f). The ependymal layer,
which was full of CXCR4-GFP prior to injury, has fewer CXCR4-GFP
cells post injury (a-b, d-e, g-h, j-k). A sprinkling of CXCR4-GFP cells
are seen toward the meninges at 1 week(g-i), but the majority of
the 2 apparently migrating populations arrive by 2 weeks(j, l-o).
Caudal to the injury, no cells are again seen in the dorsal funiculus
(k).(green:CXCR4-EGFP, blue:Hoechst). Scale bars: a, d, g, j-k: 200 μm,
b-c, e-f, h-I, k-l: 50 μm, m-o: 25 μm.
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Timecourse of CXCR4 expression post injury
To better understand the changes in the CXCR4 expres-
sion pattern post injury, we examined the time course
of CXCR4 expression. At 24 hours post injury, we
observed numerous CXCR4+ cells scattered throughout
the gray and white matter, possibly reflecting the well-
described microglial activation that occurs immediately
following SCI (Figure 4a-c). By 4 days, however, this
activation was attenuated and very few peripheral
CXCR4+ cells were present at 1 week (Figure 4d-i). By
2 weeks, however, many more CXCR4+ cells appeared
all around the periphery of the spinal cord in closed jux-
taposition to the meninges and in the dorsal funiculus
rostral to the lesion (Figure 4j, l-0). Importantly, the
dorsal funiculus caudal to the lesion again had no
CXCR4+ cells (Figure 4k). Throughout the timeline,
CXCR4 expression persisted, but the staining was pro-
gressively somewhat attenuated in the ependymal layer
Identification of the CXCR4+ cell types
The number of different cell types in the ependymal
layer of the spinal cord is unknown, and their functional
phenotypes, especially with respect to their potential as
stem/progenitor cells, remain unclear [28-33]. We used
the CXCR4-EGFP reporter mouse to help identify speci-
fic subsets of cells in the ependymal layer. First we
looked for CXCR4+ neural progenitors by co-staining
for the neural markers, GFAP and Nestin. Nestin and
GFAP both labeled cells in the ependyma and processes
extending from the ependymal layer, but neither cola-
beled with CXCR4 (Figure 5). The CXCR4+ processes
also did not colocalize with RC2 that is a marker for
radial glial progenitors (data not shown). However Nes-
tin+ fibers sometimes abutted CXCR4+ fibers indicating
a close association (Figure 5f). We also looked for
potential CXCR4+ progenitors that had migrated out
toward the periphery, but we did not see any colocaliza-
tion of GFAP+ or Nestin+ with the CXCR4+ peripheral
cells. However, CXCR4 did colocalize with CD11b and
NG2 suggesting that these cells are infiltrating macro-
phages (Figure 6). By contrast, the CXCR4+ ependymal
cells were not positive for CD11b or NG2 (data not
shown). These observations suggest that there are at
least two distinct populations of CXCR4+ cells after
SCI, ependymal cells and migrating macrophages.
Discussion
SDF1 is expressed in dCST axons
Although SDF1 has been suggested as being important
in CST development [11], its cellular origins have not
been clarified in either the normal or the injured adult
spinal cord. Shechter et al described SDF1 in the dorsal
horn of the spinal cord, but their immunohistochemistry
associated SDF1 with GFAP [20]. However the availabil-
ity of SDF1-EGFP transgenic reporter mice allowed us
to more precisely localize the chemokine, and we never
found the chemokine to be co-expressed with GFAP.
However we did find that SDF1 was consistently
expressed by neurons contributing to the main dCST
Figure 5 CXCR4-GFP cells in the ependymal layer do not have
neural progenitor markers. The CXCR4-GFP cells in the
ependymal layer have long extended processes, but do not
colocalize with GFAP+ processes at 24 hours post injury (a-b) or at
2 weeks (c-d)(red:GFAP, green:CXCR4-EGFP, blue:Hoechst). At 2
weeks, Nestin+ processes also extend from the ependymal layer,
but do not colocalize with CXCR4-GFP(e-h). Occasionally, however,
the Nestin+ processes are in close apposition to CXCR4-GFP
processes (f) (red:Nestin, green:CXCR4-EGFP, blue:Hoechst). Scale
bars: a-d: 20 μm, e-h: 50 μm.
Figure 6 CXCR4-GFP cells in the general periphery and in the
dorsal funiculus express markers of hematopoetic lineage and
not neural lineage. At 5 weeks (a, d) and at 2 weeks (b-c, e-f), the
putative migrating cell populations are positive for both CD11b and
NG2 identifying them as presumptive macrophages. No CXCR4-GFP
cells colocalized with either GFAP or Nestin. Scale bars: d: 50 μm.
[red:CD11b(a-c), NG2(d-f), GFAP(g-i), Nestin(j-l), green:CXCR4-EGFP,
blue:Hoechst].
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bundle of the CST but not the dorsolateral or ventral
tracts. Tract tracing studies confirmed the cellular iden-
tity of the SDF1-containing fibers in the spinal cord
(Figure 1e, f, g). This expression pattern is consistent
with the observations of Schonemeier et al (2008) that
SDF-1 was expressed by neurons in layer V of the
cortex.
Function of SDF1 in the spinal cord
The expression of SDF1 in CST neurons suggests that it
might have a neurotransmitter of similar function in the
spinal cord. Indeed, SDF1 has been shown to act as a
neuromodulator in some neural systems such as the hip-
pocampus [23], and other studies have reported an upre-
gulation of SDF1 post CNS disease [19]. SDF-1 has been
shown to be sufficient to overcome neurite outgrowth
inhibition mediated by CNS myelin towards cultured
postnatal dorsal root ganglion neurons. Further, local
intrathecal infusion of SDF-1 following thoracic dorsal
hemisection resulted in enhanced sprouting of corticosp-
inal tract axons into white and grey matter [34]. How-
ever, since we find that CST neurons do not express
CXCR4, it seems likely that other cells that express the
receptor indirectly mediated the effects of SDF1 infusion.
This correlates well with our observation that CXCR4+
cells appeared to migrate towards the injured spinal cord.
Our observations thus suggest that the injured CST
releases SDF1 that attracts macrophages and perhaps
other cells that help to stimulate CST axon regrowth.
CXCR4+ cells migrate specifically to the dorsal funiculus
after SCI
The ependymal layer in the spinal cord has been
reported to supply progenitors similar to the ventricular
layer in the brain, augmenting general interest in the
ependymal layer [28-33]. Several groups have implicated
SDF1/CXCR4 signaling in the migration of CXCR4+
progenitors post injury [19-21]. However, Meletis et al
deemed it unlikely that CXCR4 caused the migration of
progenitors toward injury since they saw only a few
ependymal cells expressing CXCR4 [28]. Our model
allowed us to easily identify cells expressing CXCR4 and
we observed numerous CXCR4+ cells in the ependyma.
In fact, the ependymal layer appears to express CXCR4
uniformly although this does decline somewhat subse-
quent to injury. One hypothesis is that neural progenitor
cells migrate from the ependymal layer possibly using
CXCR4 as their sensor toward areas of injury. In fact
changes in levels of SDF1 after spinal cord injury were
associated with changes in numbers of CD133-expres-
sing ependymal pericytes, suggesting a possible role in
regulating ependymal stem/progenitor cells [35].
Although our static studies did not allow us to study
the migration of cells away from the ependymal zone,
we frequently observed CXCR4+ cells that appeared to
be migrating in this fashion. However we did not find
any CXCR4+ cells that had markers of neural lineages.
There are several possible explanations for this. Progeni-
tor cells are a rarer cell population than infiltrating cells
post SCI and we may not be catching them with our
analysis. Alternatively, progenitor cells may migrate
under the influence of CXCR4 signaling and then differ-
entiate. CXCR4+ ependymal cells themselves may not
migrate away from the lesion, but may simply downre-
gulate CXCR4 in response to other signals in the
environment.
Identity of most CXCR4+ cells in the spinal cord post
injury
The major component of the two migrating populations
of CXCR4+ cells post injury seem to come from the
same lineage. They are both infiltrating cells passing
through the lesion and migrating within 2 weeks toward
sources of SDF1, be it toward the meninges alone, or in
between two sources of SDF1, the meninges and the
dCST. Most of these CXCR4 expressing cells also
express CD11b and NG2 identifying them as hemato-
poetic lineage cells, most likely macrophages [36]. The
role of macrophages after SCI is controversial, and they
have been posited to have both beneficial and deleter-
ious effects [37,38]. The high expression of SDF1 by the
dCST and the apparent release of the chemokine after
injury suggest that attraction of CXCR4+ macrophages
is part of a programmed response to injury. In turn this
suggests that that modulation of the SDF1 signaling sys-
tem may be important for regulating the inflammatory
response after SCI.
Conclusions
In the adult uninjured spinal cord, SDF1 and CXCR4 are
expressed in separate, nonadjacent regions: meninges and
dCST vs. the ependymal layer. Following the breach in
blood brain barrier post severe SCI, multiple sources of
both proteins exist contributing to specific post-injury
signaling. CXCR4-expressing macrophages migrate
through the spinal cord toward sources of SDF1 and
arrive in the peripheral spinal cord, toward the SDF1 in
the meninges, and toward the intact dCST only rostral of
the injury. This migration occurs between 1 and 2 weeks
post injury. CXCR4-expressing ependymal cells remain
post injury, but are in fewer number than in the unin-
jured spinal cord. Therefore, CXCR4 and SDF1 signaling
does introduce a trauma-specific response post SCI and
may then have a specific role.
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